University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 12 of 14
Comparison of Video-Based Versus Written Patient Education on Melanoma
NCT00826995
Comparison Of Video-based Versus Written Patient Education on Sunscreen
NCT00826306
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
NCT00826592
Journaling and Weight Loss
NCT00884195
Sorafenib in Treating Patients With Advanced Malignant Solid Tumors
NCT00810394
Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer
NCT00814788
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
NCT01047098
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00859157
The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks
NCT01103921
Accuracy of Needle Placement Into The Subacromial Space of The Shoulder
NCT01330641
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
NCT00848328
Dermatosis Papulosa Nigra
NCT00710203
Cerebral Edema in Pediatric Diabetic Ketoacidosis
NCT00629707
Development of a Metabolic Assessment Tool for Chronic Kidney Disease
NCT01838239
Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma
NCT00795665
A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression
NCT00699218
Pilot Trial of a Synbiotic in HIV+ Patients
NCT00688311
Potential Research Study Participant Registry
NCT00710489
Casinomacropeptide and Satiety
NCT01587911
Intensive Intervention for Toddlers With Autism (EARLY STEPS)
NCT00698997
Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01161719
Stent Thrombosis In Acute Coronary Syndromes
NCT00931502
Impact of Antiretroviral Therapy on Cardiac Biomarkers
NCT00641888
Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
NCT00523510
Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy
NCT00661960
Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
NCT00621829
Absorption and Metabolism of Dietary Cocoa Procyanidins in Humans
NCT01483508
Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01124721
Behavior and Driving Safety Study
NCT00575679
Drainage Amount for Removal of Thoracostomy Tube
NCT00575198
Modified Consent Form Utility
NCT00715923
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
NCT00529204
Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?
NCT00583934
Study: Effects of Strawberries on Blood Pressure
NCT01190319
Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels
NCT00579540
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
NCT00584948
Clinical Investigation on the Effects of a Vegetable Juice Treatment
NCT01161706
Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
NCT00843947
Examining Physiology and Brain Function in People With the Fragile X Premutation
NCT00879502
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
NCT00619645
STUDY: Effects of Potatoes in a Weight Loss Program
NCT01186393
Compare Effects of a Soluble Fiber on Weight and Blood Cholesterol
NCT00682916
Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation
NCT00611260
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
NCT00584402
Molecular Imaging of Breast Cancer With Breast PET/CT
NCT00584753
Abraxane and Alimta in Advanced Solid Tumors
NCT00470548
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
NCT00584272
Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells
NCT00482105
Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy
NCT00368654
Prenatal Breastfeeding Education to Reduce Nipple Pain
NCT01092156
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.